# The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life

> **NCT06535087** · — · RECRUITING · sponsor: **Wenjing Zhou** · enrollment: 600 (estimated)

## Conditions studied

- Pediatric Asthma
- Rhinitis, Allergic
- Quality of Life

## Interventions

- **DRUG:** Subcutaneous immunotherapy / Standard Treatment for Asthma and Rhinitis

## Key facts

- **NCT ID:** NCT06535087
- **Lead sponsor:** Wenjing Zhou
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-20
- **Primary completion:** 2025-06-23
- **Final completion:** 2027-05-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06535087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06535087, "The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06535087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
